Our Funds
Strategic capital solutions across private equity and open-ended fund structures, managed by Enlightenment Capital Investment Management Limited (SFC Type 9 License: BUI941).
Enlightenment Frontier Healthcare Fund LPF
Limited Partnership Fund
A private equity fund focused on frontier technology and high-growth healthcare sectors, prioritizing innovative enterprises with core technological barriers, broad market potential, and outstanding management teams. The fund empowers portfolio companies through capital and industrial resource integration to achieve long-term value enhancement.
Investment Focus
- mRNA technology platforms & drug discovery
- Premium healthcare services
- AI-powered medical devices
- Frontier deep-tech innovations
Investment Approach
- Core technological barriers required
- Clear commercialization pathway
- Outstanding management teams
- Capital + industrial resource integration
Enlightenment Frontier Opportunities OFC
Open-Ended Fund Company
The Enlightenment Frontier Opportunities Open-ended Fund Company establishes a multi-layered investment system through three sub-funds with differentiated positioning: Low-risk stable appreciation → Medium-to-high-risk return enhancement → High-risk long-term allocation, designed to meet the asset allocation needs of investors with varying risk preferences.
EF High Yield Fund — Sub-fund I
Strategy: Centered on low-risk assets, prioritizing highly secure and liquid categories to generate stable returns while strictly controlling volatility and risk.
Investment Scope
- High-rated bonds (government, policy financial, quality corporate)
- Public REITs (infrastructure / real estate)
- Money market funds
- FOF products based on fixed-income assets
Key Strengths
- Low risk level, strong return stability
- Ideal for capital preservation + steady appreciation
- Serves as the “ballast stone” in asset allocation
EF Opportunities Fund — Sub-fund II
Strategy: Focused on precisely capturing structural market opportunities to achieve higher investment returns while maintaining risk control.
Investment Scope
- Cornerstone and anchor investments in Hong Kong & A-share IPOs
- Block trades of listed companies
- Discounted equity transfers & private placements
Key Strengths
- Higher return potential than fixed-income assets
- Risk mitigated through professional timing & project selection
- Suited for investors seeking enhanced returns with moderate volatility
EF Multi-Asset Fund — Sub-fund III
Strategy: Targets high-risk, low-liquidity private equity with the primary objective of achieving long-term high returns by capturing long-term industry growth dividends.
Investment Scope
- Artificial intelligence & brain-machine interfaces
- Biopharmaceuticals (gene therapy, innovative devices)
- Deep-tech (robotics, semiconductors)
- Unlisted frontier technology companies
Key Strengths
- Share in explosive growth of frontier technology
- Significant long-term return potential
- Backed by deep research capabilities in technology sectors
- Matches the R&D → growth → exit cycle of unlisted companies
Target Investors
The Enlightenment Frontier Fund and its sub-funds primarily serve:
High-Net-Worth Individuals
Customized asset allocation based on risk preferences and capital scale
Family Offices
Multi-generational wealth management with diversified fund combinations
Institutional Investors
Including listed companies seeking professional asset management solutions
Investment philosophy: “Matching risk with return, balancing short-term and long-term objectives.”